Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Latest intelligence on NHS policy and agenda
- Which healthcare leadership teams are getting it right and why
- How innovation is driving quality and efficiency
For the best possible experience using our website we recommend you upgrade to a newer version or another browser.Close
The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.
Alternatively register for guest access